Boehringer boasts of late-stage drug potential
This is a discussion on Boehringer boasts of late-stage drug potential within the Biotechnology News forum, part of the Industry News and Updates category; A new self-assessment from Boehringer Ingelheim comes with some considerable boasting about the potential for new therapies and new ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-08-2008, 02:55 PM
|
|||
|
|||
Boehringer boasts of late-stage drug potential
A new self-assessment from Boehringer Ingelheim comes with some considerable boasting about the potential for new therapies and new indications now in its pipeline.
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Boehringer wins approval in anti-clotting drug race | industry_news | Biotechnology News | 0 | 03-27-2008 03:23 PM |
| Neurontin and abuse potential | participant1 | Managed Care Issues for Oral Drugs | 2 | 02-19-2008 07:45 PM |
© 2008 DrugManagementForum™ powered by |
 |